PRESS RELEASE, 2006-09-20
Ludesi accelerates growth through InnKap investment
Lund, Sweden - September 20, 2006 -- Ludesi AB, a global provider of bioinformatics solutions to the life science industry, today announced that the leading venture capital firm InnovationsKapital invests SEK 25 million in Ludesi. By this transaction InnovationsKapital will join Ludesi’s current investors BusinessBuilders and the Sixth AP Fund.
The funding will allow Ludesi to roll out sales of Ludesi’s innovative and successful offering for image analysis of 2D electrophoresis gels and to expand the company’s product portfolio into other expression proteomics technologies according to customer demands.
Ludesi’s image analysis offering is based on world-leading technology for advanced mathematical imaging and an analysis center performing quality-controlled analysis of 2D electrophoresis gels. By using a proprietary software technology in combination with an expert analysis center, Ludesi customers gain benefits in accuracy, throughput and cost.
"We are convinced that Ludesi will become a leading player in the protein expression analysis market. Mr Ola Forsstrom-Olsson and his team have proven that they truly have developed a unique product offering and we look forward to working together with them to continue building a successful company", says Gunnar Fernström, Investment Director at InnovationsKapital.
Ludesi was established in 2001 by CEO Ola Forsstrom-Olsson, the winner of Medicon Valley Entrepreneurship Award and nominated for MIT Technology Reviews top 100 list of the world’s best technology entrepreneurs under the age of 35. The company has since the founding developed a strong software technology and business model for 2DGE, a key technology in the growing field of expression proteomics. The company will now roll out sales of a successful first offering as well as expand the company’s product portfolio into other expression proteomics technologies.
"InnovationsKapital is the leading biotech investor for growth companies in the Nordic region and their engagement in Ludesi is aligned with our building of a world-leading software company in the field of expression proteomics. We are very pleased to have InnovationsKapital as an investor in Ludesi." comments Ola Forsstrom-Olsson, CEO at Ludesi.
About InnovationsKapital
InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. InnvationsKapital currently advises four venture funds aggregating more than EUR 300 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors. Further information about InnovationsKapital can be found at www.innkap.se
For further information, please contact:
Ola Forsstrom-Olsson, CEO, Ludesi
Phone: +46 46 286 5510
Mobile: +46 708 122 548
E-mail: ola.forsstrom-olsson@ludesi.com
Gunnar Fernström, Investment Director, InnovationsKapital
Phone: +46 31 60 91 92
Mobile: +46 703 120 502
E-mail: gf@innkap.se
2008-07-30
Ludesi Introduces Low Cost 2D Gel Image Analysis Service “Ludesi Basic” to Meet Broader Market Demand
Read more
2008-05-13
New Ludesi REDFIN 2D Gel Image Analysis Software Upgrade Enables Experiment Sharing and Collaboration Worldwide
Read more
2008-04-29
Ludesi Wins Frost & Sullivan Global 2D Gel Electrophoresis Emerging Technology of the Year Award
Read more
2008-04-29
Ludesi Honoured with 2008 Frost & Sullivan Global Emerging Technology of the Year Award
Read more
2008-04-28
Ludesi REDFIN first 2D gel software to be certified for Windows Vista
Read more
2008-04-02
Ludesi CEO Lectures on Improving Discovery Potential in 2D Gel Image Analysis at NIH BIO-TRAC Training Courses
Read more
2008-03-17
Ludesi Presents Latest 2D Gel Image Analysis Technology and Research Results for 2D Gel Data Quality at US HUPO 2008
Read more
2008-01-22
Ludesi CEO speaking on "measurements of correctness and completeness in 2D gel image analysis" at Peptalk 2008
Read more
2007-12-03
Ludesi Announces New Image & Data Management Software for its 2D Gel Image Analysis Service
Read more
2007-11-12
Ludesi Selected by Vertex Pharmaceuticals
Read more
2007-11-12
Ludesi Hires Application Specialists from Bio-Rad, GE Healthcare & Nonlinear Dynamics
Read more
2007-10-17
Ludesi Presents Results from Scientific Study on Discovery Potential in 2D Gel Image Analysis
Read more
2007-06-19
Ludesi CEO to Lecture on Quality Control in 2D Gel Image Analysis at NIH BIO-TRAC
Read more
2007-06-11
Ludesi 2DGE Image Analysis Service Improves Discovery Potential in Proteomics
Read more
2007-02-20
DSM Nutritional Products Contracts Ludesi for 2D Gel Image Analysis
Read more
2006-11-14
Johns Hopkins Bayview Proteomics Center Chooses Ludesi
Read more
2006-10-26
Ludesi Exhibiting and Presenting at International Proteomics Conference
Read more
2006-09-20
Ludesi Accelerates Growth Through InnKap Investment
Read more
2006-08-31
Ludesi Co-Sponsoring Major Proteomics Meeting
Read more
2006-05-22
Ludesi Announces Mitsubishi Pharma Corporation Sign Agreement on 2D Gel Image Analysis
Read more